Biotech Values

[DewDiligence]

SVA—This buyout is the kind of risk I was referring to in #msg-115335282:

http://www.prnewswire.com/news-releases/sinovac-biotech-ltd-enters-into-definitive-agreement-for-going-private-transaction-300479485.html

If you have no BoD representation, there’s little or no impediment to a self-dealing transaction by the parent company, as was the case with Genzyme’s (and various other companies’) “tracking stocks” in the previous decade.